ub.xmlui.mirage2.page-structure.muninLogoub.xmlui.mirage2.page-structure.openResearchArchiveLogo
    • EnglishEnglish
    • norsknorsk
  • Velg spraaknorsk 
    • EnglishEnglish
    • norsknorsk
  • Administrasjon/UB
Vis innførsel 
  •   Hjem
  • Det helsevitenskapelige fakultet
  • Institutt for klinisk medisin
  • Artikler, rapporter og annet (klinisk medisin)
  • Vis innførsel
  •   Hjem
  • Det helsevitenskapelige fakultet
  • Institutt for klinisk medisin
  • Artikler, rapporter og annet (klinisk medisin)
  • Vis innførsel
JavaScript is disabled for your browser. Some features of this site may not work without it.

Impact of hidradenitis suppurativa on work loss, indirect costs and income

Permanent lenke
https://hdl.handle.net/10037/25401
DOI
https://doi.org/10.1111/bjd.17101
Thumbnail
Åpne
article.pdf (259.6Kb)
Publisert versjon (PDF)
Dato
2018-08-18
Type
Journal article
Tidsskriftartikkel
Peer reviewed

Forfatter
Tzellos, Thrasyvoulos; Yang, H; Mu, F; Calimlim, B; Signorovitch, J
Sammendrag
Background Hidradenitis suppurativa (HS), a chronic cutaneous disease, can negatively affect work life. Objectives This retrospective cohort study evaluates the indirect burden among employed patients with HS in the U.S.A.

Methods Newly diagnosed and general patients with HS, who were employees (age 18–64 years) from a large claims database (Q1 1999 to Q1 2015), were matched 1 : 5 to controls. Income growth and risk of leaving the workforce were assessed among the newly diagnosed HS and control cohorts in the 5-year study period. Income, work loss days and indirect costs (absenteeism and disability) were assessed among the general HS and control cohorts in the 1-year study period.

Results Newly diagnosed (n = 1003, mean age 39 5 years, 66 3% female) and general patients with HS (n = 1204, mean age 39 9 years, 69 1% female) were matched to 5015 and 6020 controls, respectively. Newly diagnosed patients with HS had significantly slower income growth ($324 per year) and higher risk of leaving the workforce (adjusted hazard ratio 1 65, 95% confidence interval 1 45– 1 88) compared with controls (all P < 0 05). General patients with HS had more total days of work loss (18 4 vs. 7 7), higher annual total indirect costs ($2925 vs. $1483) and lower annual income ($54 925 vs. $62 357) than controls (all P < 0 001).

Conclusions Patients with newly diagnosed HS and general patients with HS experienced a greater indirect burden than matched controls.

Forlag
Wiley
Sitering
Tzellos T, Yang H, Mu, Calimlim, Signorovitch. Impact of hidradenitis suppurativa on work loss, indirect costs and income. British Journal of Dermatology (2019) 181, pp147–154
Metadata
Vis full innførsel
Samlinger
  • Artikler, rapporter og annet (klinisk medisin) [1974]
Copyright 2018 The Author(s)

Bla

Bla i hele MuninEnheter og samlingerForfatterlisteTittelDatoBla i denne samlingenForfatterlisteTittelDato
Logg inn

Statistikk

Antall visninger
UiT

Munin bygger på DSpace

UiT Norges Arktiske Universitet
Universitetsbiblioteket
uit.no/ub - munin@ub.uit.no

Tilgjengelighetserklæring